How are energy investors positioned?
James W. Bracke, a director at NVE Corp (NASDAQ:NVEC), has recently made a purchase of the company’s common stock, according to a filing with the Securities and Exchange Commission. On April 4, Bracke acquired 100 shares at a price of $57.97 per share, totaling $5,797. This transaction increased his direct ownership to 600 shares. The purchase comes as the stock trades near its 52-week low of $57, down approximately 28% over the past year. According to InvestingPro analysis, the stock currently appears slightly undervalued.
NVE Corp, based in Eden Prairie, Minnesota, operates in the semiconductor and related devices industry. The company maintains impressive gross profit margins of 83% and offers a substantial 6.8% dividend yield. The company’s stock transactions, as reflected in SEC filings, are closely monitored by investors for insights into the confidence of company insiders. InvestingPro subscribers can access 12 additional key insights and a comprehensive Pro Research Report covering insider trading patterns and financial health metrics.
In other recent news, NVE Corporation reported its fourth-quarter 2024 earnings, revealing a mixed financial performance. The company achieved earnings per share of $0.63, aligning with market expectations, while total revenue reached $5.06 million, marking a 25% decline from the same quarter last year. Despite the revenue drop, NVE Corporation managed to improve its gross margins to 84%, reflecting strong operational efficiency. The company also noted a significant decrease in product and R&D sales, contributing to the revenue decline. Furthermore, NVE Corporation is focusing on new product developments in the medical and AI sensor markets to drive future growth. The company has been investing heavily in research and development, with expenses increasing by 61% to support new product initiatives. Analysts have not provided any recent upgrades or downgrades for NVE Corporation’s stock. The company remains optimistic about its business fundamentals, citing potential growth in the medical device and AI sensor markets.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.